Toosendanin

Toosendanin has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 30, 2026: “Reducing a cell-division brake reduced lung scarring in mice”.

Intervention

1 paper studies it1 findingUpdated

PubChemChEBI

See all 1

  • 1 lab in 1 country
  • Funders: Ewha Womans University and 3 more
  • Animals1

What did studies of Toosendanin find?

1

Studies of Toosendanin measured 1 outcome; the most studied are pulmonary fibrosis (1 study).

Pulmonary fibrosis

downin mice1

1 study
  1. Toosendanin decreases pulmonary fibrosis in mice (BLM-induced PF).

    “This compound suppressed p16 promoter activity, effectively restored autophagic flux, and attenuated BLM-induced PF in vivo.”

    AnimalsBLM-induced PFlung

    Reducing a cell-division brake reduced lung scarring in mice

    Signal transduction and targeted therapy

More on Pulmonary fibrosis

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 paper in 12 months
Signal Transduction and Targeted Therapy

Reducing a cell-division brake reduced lung scarring in mice

A 14-day experiment in male mice tested a compound that lowered production of a protein involved in stopping cell division and reduced lung scarring.A 14-day experiment in male mice tested a compound that lowered production of a protein involved in stopping cell division and reduced lung scarring.

Mouse studyLung